Jakavi – Ruxolitinib 20mg Tablet
Description
RUXOLITINIB (JAKAVI) TABLET – TREATMENT FOR CHRONIC IDIOPATHIC MYELOFIBROSIS
Ruxolitinib or Jakavi 20mg Tablet is used to treat chronic idiopathic myelofibrosis and polycythemia vera.
Jakavi 20mg Tablet can be taken with or without food, but it is best to take it at the same time every day to reap the maximum advantages. Your doctor will determine the appropriate dosage and frequency of administration. This will vary depending on what you are being treated for and may change from time to time. You must take it exactly as prescribed by your doctor. If used incorrectly or in excess, it might have dangerous negative effects.
Polycythemia vera is a form of blood cancer that causes an excess of red blood cells to be produced. This can result in blood clots and other significant health problems. Jakavi 20mg Tablet destroys or slows the growth of cancer cells while also preventing cancer cell multiplication. It is a highly effective but extremely toxic medication, and you should evaluate the risks and benefits with your doctor. While receiving this medication, avoid drinking alcohol or smoking, and drink lots of water to stay hydrated.
Fedelty Health Care is a Ruxolitinib wholesaler, Pharmaceutical Cargo Bulk Exporter & Hospital Supply.
USES OF RUXOLITINIB (JAKAVI) TABLET
- Polycythemia vera
- Chronic idiopathic myelofibrosis
WORKS OF RUXOLITINIB (JAKAVI) TABLET
Jakavi 20mg Tablet is a cancer-fighting medicine. It works by preventing the aberrant protein from signaling cancer cells to proliferate. This aids in the prevention or slowing of the spread of cancer cells.
Fedelty Health Care is a Ruxolitinib wholesaler, Pharmaceutical Cargo Bulk Exporter & Hospital Supply.
SIDE EFFECTS OF RUXOLITINIB (JAKAVI) TABLET
The majority of adverse effects do not necessitate medical treatment and will go away as your body adjusts to the medication. Consult your doctor if they persist or if you are concerned.
- Headache
- Dizziness
- Low blood platelets
- Anemia (low number of red blood cells)
WARNING & PRECAUTIONS
- Driving
Jakavi 20mg Tablet may impair your alertness, impair your vision, or cause you to feel drowsy and dizzy. If you have any of these symptoms, do not drive.
- Kidney
In people with kidney illness, Jakavi 20mg Tablet should be used with caution. Jakavi 20mg Tablet dosage may need to be adjusted. Please consult your physician.
In patients with moderate to severe kidney dysfunction, the use of Jakavi 20mg Tablet is not recommended.
- Liver
In patients with liver problems, Jakavi 20mg Tablet should be used with caution. Jakavi 20mg Tablet dosage may need to be adjusted. Please consult your physician.
- Pregnancy
Jakavi 20mg Tablet may be harmful if used while pregnant. Although there has been little human research, animal studies have revealed detrimental consequences on the growing fetus. Before prescribing it to you, your doctor will consider the advantages as well as any potential hazards. Please consult your physician.
Fedelty Health Care is a  Ruxolitinib third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.
